CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
hearing aid amplification +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05292534
NCT05292534N/ACompleted

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Sonova AG·interventional·Posted Mar 23, 2022·Updated Jul 5, 2024

In Brief

A clinical study evaluating hearing aid amplification and hearing aid amplification with an added sound for Hearing Loss, Sensorineural and Tinnitus. Completed, enrolled 38 participants across 1 site.

Detailed Summary

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 23, 2022
Enrollment StartJun 1, 2022
Primary CompletionSep 20, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.3 years ago

Interventions

hearing aid amplificationdevice

Hearing aid will be fit to prescribed participant hearing loss.

hearing aid amplification with an added sounddevice

Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated.